In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...